This compound is a pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients. It is a stereochemically defined, salt-like molecule with multiple aromatic rings and ether linkages, primarily supplied as a research or manufacturing intermediate.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1431329-06-4
(3aR,7aR)-4'-(Benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-2-ium methanesulfonate
pharmaceutical intermediate synthesis
3-(chloromethyl)-2-(1-isopropyl-1H-pyrazol-5-yl)pyridine hydrochloride
pharmaceutical intermediate synthesis
1-N-Boc-pyrrolidin-2-ylboronic acid
pharmaceutical intermediate synthesis
Ethyl (I+-R,I2S)-I2-(benzoylamino)-I+--hydroxybenzenepropanoate
pharmaceutical intermediate synthesis
Ethyl 2-(2-benzyl-3-hydroxypropanamido)acetate
pharmaceutical intermediate for alvimopan impurities
4-[4-[[[[2-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
Pharmaceutical reference standard intermediate
1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride
Pharmaceutical intermediate for synthesis
(3R,5R)-3-Amino-5-hydroxy-piperidine-1-carboxylic acid tert-butyl ester
Pharmaceutical intermediate
(2R,3S,4S)-4-[2,2-dimethyl-4-(phenylmethoxymethyl)-1,3-dioxolan-4-yl]-1-(4-methylpiperazin-1-yl)-2,3,4-tris(phenylmethoxy)butan-1-one;oxalic acid
XUHXSEWYTGMCOD-RXVWKENOSA-N
CC1(OCC(O1)(COCC2=CC=CC=C2)[C@H]([C@@H]([C@H](C(=O)N3CCN(CC3)C)OCC4=CC=CC=C4)OCC5=CC=CC=C5)OCC6=CC=CC=C6)C.C(=O)(C(=O)O)O
—